Ventas, Inc. (VTR) Stock Analysis and Metrics

Ventas

NYSE: VTR

$100.52 ▲ +2.60 (+2.66%)

At close: Jul 24, 2026 · 3:59 PM UTC

Financial Ratios

Market Cap46.62 Bn

P/E179.03

P/S7.60

Div. Yield0.00

ROIC (Qtr)0.00

Revenue Growth (1y) (Qtr)22.01

Add ratio to table…

About

Ventas, Inc. is an S&P 500 company focused on delivering strong sustainable shareholder returns by enabling exceptional environments that benefit a large and growing aging population. The company owns and invests in senior housing communities outpatient medical buildings research centers hospitals and other healthcare facilities located across North America and the United Kingdom. As of December 31 2025 it held interests in 1 409 properties comprising 1 374 reportable segment properties and 35 properties held by unconsolidated real estate entities. Headquartered in Chicago Illinois the firm maintains additional offices in Louisville Kentucky and New York New York. It has elected to be taxed as a real estate investment trust under the Internal Revenue Code since 1999.

Ventas generates revenue principally from leasing its owned properties to tenants under various lease structures. In the senior housing operating segment the company receives a share of net operating income after paying third party managers. In the outpatient medical and research segment it collects rent from health systems academic institutions and private medical practices. In the triple net leased segment tenants pay all property related expenses plus base rent under absolute net leases. Additionally the firm earns management fees promote income and other service revenues through its third party institutional private capital management platform. Interest income from loans and returns on investments in unconsolidated entities also contribute to overall revenue.

The company operates through the following segments: senior housing operating portfolio (SHOP) outpatient medical and research portfolio (OM&R) and triple net leased properties (NNN).

• The senior housing operating portfolio SHOP consists of independent living assisted living memory care and continuing care retirement communities The company typically engages third party managers to operate these communities while retaining responsibility for operational costs expenses and liabilities Through its proprietary data and analytics platform Ventas OI it gathers information from internal and external sources to support decision making enhance resident care and guide capital expenditures As of December 31 2025 the segment comprised 752 properties managed by 39 third party operators with notable concentrations in entities such as Atria Senior Living Sunrise Senior Living and Le Groupe Maurice.

• The outpatient medical and research portfolio OM&R focuses on acquiring owning developing leasing and managing outpatient medical buildings and research centers These properties are often situated on or near health system campuses and are leased to health systems academic medical centers universities biotech firms and pharmaceutical companies Tenants require specialized space for patient examination treatment diagnostic imaging outpatient surgery and research activities The firm provides property management leasing marketing and advisory services through its Lillibridge subsidiary and its stake in PMB Real Estate Services LLC As of year end 2025 the segment included 409 properties.

• The triple net leased properties NNN segment comprises senior housing communities skilled nursing facilities long term acute care facilities freestanding inpatient rehabilitation facilities and other healthcare facilities leased to tenants under triple net or absolute net agreements Tenants assume responsibility for all property related expenses including maintenance utilities taxes insurance and capital expenditures The portfolio includes significant exposure to operators such as Brookdale Senior Living Kindred Healthcare and Ardent Health Partners As of December 31 2025 the segment contained 213 properties.

Ventas holds a prominent position among healthcare real estate investment trusts in North America The firm competes with other publicly traded and private healthcare REITs as well as with direct property owners developers banks insurance companies pension funds and private equity groups Its scale diversified portfolio and focus on assets serving an aging population provide a stable cash flow base The company benefits from its REIT structure which offers tax efficiency and from its internal data analytics platform that supports operational efficiency and informed investment decisions These strengths help it maintain access to capital and attract high quality tenants and partners

The company serves a varied mix of operators and tenants across its segments In the senior housing operating segment key managers include Atria Senior Living Sunrise Senior Living and Le Groupe Maurice In the triple net leased segment major tenants are Brookdale Senior Living Kindred Healthcare and Ardent Health Partners In the outpatient medical and research segment tenants consist of health systems academic medical centers universities biotech firms and pharmaceutical companies Additionally the firm earns income from its investments in unconsolidated entities such as its stakes in Ardent and Atria and through its third party institutional private capital management platform which works with institutional investors including state pension funds and sovereign wealth funds

Investment Thesis

▲ Bull case

Ventas, Inc. is positioned to capture outsized returns from the accelerating demographic surge of baby boomers turning 80 beginning in 2026, a trend that will drive near-doubling of the core senior housing demand cohort over the next five years, yet the company’s guidance only reflects a fraction of this potential. Management highlighted that senior housing construction starts remain at historic lows of approximately 1,500 new units in Q1, and with a three- to four-year development lag, meaningful supply response is unlikely before 2029, creating a durable structural imbalance where demand growth of nearly 30% in the over-80 population will far outpace new supply. This imbalance is already translating into pricing power, as evidenced by in-house rate increases running at nearly 8% year-over-year in Q1, and street rates improving across geographies, yet the company’s full-year revenue growth guidance of 8.75% appears conservative given that occupancy growth alone—projected at 300 basis points for the year—could drive substantially higher NOI expansion when combined with operating leverage. The fact that SHOP same-store NOI margins expanded 170 basis points to 30% in Q1, with incremental margins reaching 50%, indicates that the company is already extracting significant efficiency gains from scale, and as occupancy climbs toward 90%+ across more communities, incremental margins could rise toward 70%, unlocking additional profitability not fully priced into current expectations. Furthermore, Ventas, Inc.’s strategic focus on acquiring assets below replacement cost—exemplified by the $540 million Revel portfolio purchase at a discount despite its luxury amenities—combined with its ability to drive unlevered IRRs in the low- to mid-teens through Ventas OI initiatives, creates a self-reinforcing flywheel: acquired assets generate immediate cash flow, operational improvements boost NOI, and enhanced performance attracts better operators and repeat sellers, expanding the pipeline of high-quality off-market deals. With over 90% of year-to-date investments being relationship-driven and more than 60% sourced off-market, the company is increasingly insulated from competitive bidding pressures, allowing it to maintain disciplined underwriting even as cap rates drift into the high-6s range. This combination of structural demand tailwinds, operational scalability, and proprietary deal sourcing suggests the market is underestimating the durability and acceleration of Ventas, Inc.’s growth profile beyond 2026.

Ventas, Inc. is positioned to capture outsized returns from the accelerating demographic surge of baby boomers turning 80 beginning in 2026, a trend that will drive near-doubling of the core senior housing demand cohort over the next five years, yet the company’s guidance only reflects a fraction of this potential. Management highlighted that senior housing construction starts remain at historic lows of approximately 1,500 new units in Q1, and with a three- to four-year development lag, meaningful supply response is unlikely before 2029, creating a durable structural imbalance where demand growth of nearly 30% in the over-80 population will far outpace new supply. This imbalance is already translating into pricing power, as evidenced by in-house rate increases running at nearly 8% year-over-year in Q1, and street rates improving across geographies, yet the company’s full-year revenue growth guidance of 8.75% appears conservative given that occupancy growth alone—projected at 300 basis points for the year—could drive substantially higher NOI expansion when combined with operating leverage. The fact that SHOP same-store NOI margins expanded 170 basis points to 30% in Q1, with incremental margins reaching 50%, indicates that the company is already extracting significant efficiency gains from scale, and as occupancy climbs toward 90%+ across more communities, incremental margins could rise toward 70%, unlocking additional profitability not fully priced into current expectations. Furthermore, Ventas, Inc.’s strategic focus on acquiring assets below replacement cost—exemplified by the $540 million Revel portfolio purchase at a discount despite its luxury amenities—combined with its ability to drive unlevered IRRs in the low- to mid-teens through Ventas OI initiatives, creates a self-reinforcing flywheel: acquired assets generate immediate cash flow, operational improvements boost NOI, and enhanced performance attracts better operators and repeat sellers, expanding the pipeline of high-quality off-market deals. With over 90% of year-to-date investments being relationship-driven and more than 60% sourced off-market, the company is increasingly insulated from competitive bidding pressures, allowing it to maintain disciplined underwriting even as cap rates drift into the high-6s range. This combination of structural demand tailwinds, operational scalability, and proprietary deal sourcing suggests the market is underestimating the durability and acceleration of Ventas, Inc.’s growth profile beyond 2026.

▼ Bear case

Ventas, Inc. faces mounting pressure from rising operational complexity and cost inflation that may erode the incremental margin expansion thesis, particularly as the company scales its SHOP portfolio to over 60% of total business while integrating diverse operators under the Ventas OI platform. Despite claims of 50% incremental margins in Q1, the company acknowledged that operating expenses grew 5.8% year-over-year, driven significantly by winter storm-related costs and higher occupancy-related variable expenses, and CFO Robert Probst explicitly tied the full-year OpEx guidance increase from 5.0% to 5.5% to volume-driven factors, signaling that growth itself is becoming a cost driver. As occupancy rises toward 90%+, the marginal cost of serving additional residents—including food, labor, utilities, and care services—may not decline proportionally, challenging the assumption that incremental margins will sustain or improve beyond current levels. Moreover, while management emphasized the value proposition of safety, socialization, and peace of mind, they offered no concrete evidence that residents understand or accept price increases tied to operational costs, raising the risk of pushback or reduced length of stay if pricing outpaces perceived value, especially in affluent markets where the Revel portfolio targets price-sensitive, active seniors. The company’s reliance on off-market, relationship-driven deals—while currently a strength—could become a liability if repeat sellers begin to demand higher prices as they recognize Ventas, Inc.’s appetite for assets, potentially compressing acquisition yields and forcing the company into more competitive, brokered processes where its win rates may decline. Additionally, the Brookdale transition assets, which were highlighted as a future NOI growth opportunity requiring additional CapEx to become competitive, represent a significant execution risk: if the planned investments do not deliver the anticipated $50 million NOI upside by 2027, or if integration with five different operators proves more complex than anticipated, the drag on overall SHOP performance could offset gains from newer acquisitions like Revel. Finally, while Ventas, Inc. touts its ability to manage multiple operators at scale, the increasing operator count to 44 introduces coordination challenges, inconsistent execution of Ventas OI initiatives, and potential dilution of brand standards, particularly as the company prioritizes growth over portfolio homogeneity, which could undermine the very platform advantages it claims to possess.

Ventas, Inc. faces mounting pressure from rising operational complexity and cost inflation that may erode the incremental margin expansion thesis, particularly as the company scales its SHOP portfolio to over 60% of total business while integrating diverse operators under the Ventas OI platform. Despite claims of 50% incremental margins in Q1, the company acknowledged that operating expenses grew 5.8% year-over-year, driven significantly by winter storm-related costs and higher occupancy-related variable expenses, and CFO Robert Probst explicitly tied the full-year OpEx guidance increase from 5.0% to 5.5% to volume-driven factors, signaling that growth itself is becoming a cost driver. As occupancy rises toward 90%+, the marginal cost of serving additional residents—including food, labor, utilities, and care services—may not decline proportionally, challenging the assumption that incremental margins will sustain or improve beyond current levels. Moreover, while management emphasized the value proposition of safety, socialization, and peace of mind, they offered no concrete evidence that residents understand or accept price increases tied to operational costs, raising the risk of pushback or reduced length of stay if pricing outpaces perceived value, especially in affluent markets where the Revel portfolio targets price-sensitive, active seniors. The company’s reliance on off-market, relationship-driven deals—while currently a strength—could become a liability if repeat sellers begin to demand higher prices as they recognize Ventas, Inc.’s appetite for assets, potentially compressing acquisition yields and forcing the company into more competitive, brokered processes where its win rates may decline. Additionally, the Brookdale transition assets, which were highlighted as a future NOI growth opportunity requiring additional CapEx to become competitive, represent a significant execution risk: if the planned investments do not deliver the anticipated $50 million NOI upside by 2027, or if integration with five different operators proves more complex than anticipated, the drag on overall SHOP performance could offset gains from newer acquisitions like Revel. Finally, while Ventas, Inc. touts its ability to manage multiple operators at scale, the increasing operator count to 44 introduces coordination challenges, inconsistent execution of Ventas OI initiatives, and potential dilution of brand standards, particularly as the company prioritizes growth over portfolio homogeneity, which could undermine the very platform advantages it claims to possess.

Geographical Breakdown of Revenue (2025)

Peer Comparison

Companies in the REIT - Healthcare Facilities

S.No.	Ticker	Company	Market Cap	P/E	P/S	Total Debt (Qtr)
1	WELL	Welltower Inc.	172.91 Bn	122.84	12.78	17.93 Bn
2	VTR	Ventas, Inc.	46.62 Bn	179.03	7.60	-
3	DOC	Healthpeak Properties, Inc.	15.34 Bn	69.22	-33.80	0.25 Bn
4	OHI	Omega Healthcare Investors Inc	15.14 Bn	23.22	12.25	0.43 Bn
5	AHR	American Healthcare REIT, Inc.	10.71 Bn	194.58	4.76	1.51 Bn
6	CTRE	CareTrust REIT, Inc.	9.45 Bn	28.24	199.40	0.50 Bn
7	HR	Healthcare Realty Trust Inc	7.33 Bn	-	5.04	4.10 Bn
8	SBRA	Sabra Health Care REIT, Inc.	5.09 Bn	36.93	17.13	0.04 Bn

Research Tools

Developers

About

Investment Thesis

Statement, Business Segments Breakdown of Revenue (2025)

Geographical Breakdown of Revenue (2025)

Peer Comparison

Research Tools

Developers

About

Investment Thesis

Statement, Business Segments Breakdown of Revenue (2025)

Geographical Breakdown of Revenue (2025)

Peer Comparison

Create an account

Sign In

Reset Password